Dendritic cell vaccine for relapsed neuroblastoma patient induces complete remission

One year after his last treatment, a six-year-old boy with recurrent neuroblastoma is in complete remission for his high-risk metastatic cancer.

http://www.eurekalert.org/pub_releases/2013-01/skc-dcv012913.php